Market revenue in 2023 | USD 150.9 million |
Market revenue in 2030 | USD 261.8 million |
Growth rate | 8.2% (CAGR from 2023 to 2030) |
Largest segment | Anti- inflammatories |
Fastest growing segment | Combination therapy |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Anti- inflammatories, Bronchodilators, Combination therapy |
Key market players worldwide | Teva Pharmaceutical Industries Ltd, GSK PLC, Merck & Co Inc, Roche Holding AG, AstraZeneca PLC, Boehringer Ingelheim, Sanofi SA, Koninklijke Philips NV, BD, Corvus Pharmaceuticals Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to asthma therapeutics market will help companies and investors design strategic landscapes.
Anti- inflammatories was the largest segment with a revenue share of 61.7% in 2023. Horizon Databook has segmented the South Africa asthma therapeutics market based on anti- inflammatories, bronchodilators, combination therapy covering the revenue growth of each sub-segment from 2018 to 2030.
South Africa’s asthma therapeutics market is expected to witness lucrative growth over the forecast period. Growth can be attributed to the increasing prevalence of respiratory diseases, supportive government initiatives, and growing demand for asthma therapeutics.
In addition, several Thoracic Societies, such as the South African Thoracic Society, Nigerian Thoracic Society, East African Thoracic Society, and others, are working toward the challenges of respiratory diseases in Africa.
The burden of Chronic Respiratory Disorders (CRDs) in the region is increasing. Furthermore, South Africa continues to exhibit one of the highest rates of childhood asthma prevalence across the African continent.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa asthma therapeutics market , including forecasts for subscribers. This country databook contains high-level insights into South Africa asthma therapeutics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account